Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Abbott Laboratories buy gerihouse

Start price
€75.43
20.09.19 / 50%
Target price
€93.00
21.04.20
Performance (%)
18.72%
End price
€89.55
21.04.20
Summary
This prediction ended on 21.04.20 with a price of €89.55. The prediction had a final performance of 18.72%. Dividends of €0.95 are taken into consideration when calculating the performance. gerihouse has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Abbott Laboratories 2.704% 2.704% 14.956% 1.373%
iShares Core DAX® 2.149% 5.415% 21.385% 22.595%
iShares Nasdaq 100 0.838% 1.926% 44.386% 55.330%
iShares Nikkei 225® 1.143% 2.887% 27.641% 9.481%
iShares S&P 500 1.265% 3.698% 33.327% 49.646%

According to gerihouse what are the pros and cons of Abbott Laboratories for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
High dividend yield expected
Revenue growth >5% per year expected
Top 10 in its market
Known brand
Cons

Comments by gerihouse for this prediction

In the thread Abbott Laboratories diskutieren
Prediction Buy
Perf. (%) 18.72%
Target price 85.000
Change
Ends at 21.04.20

Der Medizintechnikkonzern Abbott Laboratories gehört zu den wenigen Unternehmen, die trotz wackliger Konjunktur ihre Gewinnziele für dieses Jahr heraufsetzen. Nachdem Abbott im ersten Halbjahr mit 1,7 Milliarden Dollar unterm Strich 46 Prozent mehr verdient hat, dürften 2019 insgesamt über drei Milliarden Dollar bleiben. Das wäre das beste Ergebnis, seit Abbott vor sechs Jahren sein Pharmageschäft unter dem Namen AbbVie abspaltete und als eigenes Unternehmen an die Börse brachte. Schwerpunkt des Geschäfts sind seitdem Medizintechnik und Diagnostik. Abbott-Aktien kommen derzeit auf 137 Milliarden Euro Börsenwert.

(Quelle Wirtschaftswoche 37)

Prediction Buy
Perf. (%) 18.72%
Target price 89.000
Change
Ends at 21.04.20

Kursziel geändert auf 89,0

Prediction Buy
Perf. (%) 18.72%
Target price 93.000
Change
Ends at 21.04.20

Kursziel geändert auf 93,0

In the thread Trading Abbott Laboratories
Prediction Buy
Perf. (%) 18.72%
Target price 93.000
Change
Ends at 21.04.20

Buy beendet

Stopped prediction by gerihouse for Abbott Laboratories

buy
Abbott Laboratories

Start price
Target price
Perf. (%)
€103.36
19.09.22
€130.00
19.09.23
-8.59%
20.09.23

Could be worthwhile Investment >10% per year
High dividend yield expected
Revenue growth >5% per year expected
Top 10 in its market